Precision Oncology Forum

151 W 5th Street,Cincinnati OH 45202

01 April, 2022

Description

Precision Oncology (PO) Forum 2022 Closing the gap between knowledge and practice Objectives: As a result of participating in this activity, participants should be able to: compare the latest advances in the field of precision oncology, especially in testing approaches.discuss the application of these advances in patient care.analyze real-world experiences and case studies of integrating precision medicine into clinical practice. Target Audience: All healthcare professionals with interest in cancer care from all specialties and disciplines including physicians, oncology nurse practitioners, physician assistant genetic counselors, scientists, pharmacists, nurses, and other allied healthcare professionals. Activities: Didactic lectures: When possible, speakers will be asked to start their presentation with short case presentations (1-2 Slides) and then close the talk with a summary of the patients’ treatment and outcome! Round Table: Experts from different healthcare systems will present their experience in implementing PO in their settings and discuss challenges and successes (what worked and what did not work). Consensus recommendations statement may come out of this discussion. Satellite Symposia: Industry-sponsored activity that focuses on specific areas of interest in PO. Exhibits: For sponsors, supporters, and collaborators. Themes: PO in cancer prevention, screening, and early detection Available testing methods and their utilization in practice and challenges of testing PO in lung cancer PO in other solid tumorsRare cancers/mutations Site agnostic actionable targets Case studies of real-world application of PO in practiceForum Directors: Abdul Jazieh, MD, MPH Christian Rolfo, MD, PHD Partnership with the University of Cincinnati: Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Innovative Healthcare Institute (IHCI). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. Designation Statement: The University of Cincinnati designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty: The faculty will include Experts from leading cancer centers with different backgrounds, regional experts, and local experts. The Local faculty: PO leaders in each group: UC, the Christ Hospital, TriHealth, OHC. The Regional Faculty (From the three states: OH, KY, IN): PO Leaders from OSU, Cleveland Clinics, IU, UK in Lexington, and Louisville. The National Faculty: PO leaders from leading US institutions with different background expertise. Organizers and Collaborators: Powered by the Innovative Healthcare Institute, Journal of Immunotherapy and Precision Oncology in collaboration with the International Society of Liquid Biopsy. NOTE: Images and videos will be taken at the event.